NovaCell Technology Overview

  • Founded
  • 2000

Founded
  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $9.1M

  • Investors
  • 4

NovaCell Technology General Information

Description

Developer of biomaterials and pharmaceuticals intended to balance the immune system in a healthy way. The company's provides contract research services for new drug development as well as conducting collaborative research products with various other domestic and foreign universities, research labs and institutions, enabling patients to cure diseases, such as atopy, asthma, dry eye disease, and inflammatory bowel disease.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Primary Office
  • 77, Cheongam-ro, Nam-gu
  • Pohang University of Science and Technology
  • Pohang-si, Gyeongsangbuk-do
  • South Korea
+82 000-000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NovaCell Technology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC $9.1M 000.00 Completed Generating Revenue
1. Later Stage VC 28-Sep-2020 00.000 00.000 Completed Generating Revenue
To view NovaCell Technology’s complete valuation and funding history, request access »

NovaCell Technology Patents

NovaCell Technology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2020152723-A Novel multi-functional peptides and use thereof Pending 19-Mar-2019 000000000
US-20200405802-A1 Novel multi-functional peptides and use thereof Pending 19-Mar-2019 000000000
EP-3711745-A3 Novel multi-functional peptides and use thereof Pending 19-Mar-2019 000000000 0
EP-3711745-A2 Novel multi-functional peptides and use thereof Pending 19-Mar-2019 000000000 0
US-10421781-B2 Antimicrobial peptide and use thereof Active 18-Nov-2015 C07K7/06 0
To view NovaCell Technology’s complete patent history, request access »

NovaCell Technology Executive Team (5)

Name Title Board Seat Contact Info
Taehoon Lee Ph.D Chief Executive Officer, Owner & President
In-Jung Kang Chief Financial Officer & Finance Director
Seonho Ki Ph.D Chief Technology Officer
Kyunghee Jang CDO & Development Director
Hwang Man-soon CSO & Director
To view NovaCell Technology’s complete executive team members history, request access »

NovaCell Technology Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
AION Partners (New York) Real Estate Minority 000 0000 000000 0
Huons Global Corporation Minority 000 0000 000000 0
Korea Investment Partners Venture Capital Minority 000 0000 000000 0
Quantum Ventures Korea Venture Capital Minority 000 0000 000000 0
To view NovaCell Technology’s complete investors history, request access »